IOP-lowering efficacy and tolerability of preservative-free tafluprost 0.0015% among patients with ocular hypertension or glaucoma
Hommer A., Mohammed Ramez O., Burchert M., Kimmich F.
View publication
-
Therapeutic Area
Glaucoma
-
Categories
Clinical development
-
Affiliations
Sanatorium Hera, Vienna, Austria; Santen Germany, Germering, Germany; Eyecons, Pfinztal, Germany